DK1303276T3 - Biotilgængelig doseringsform af loratadin - Google Patents

Biotilgængelig doseringsform af loratadin

Info

Publication number
DK1303276T3
DK1303276T3 DK01940893T DK01940893T DK1303276T3 DK 1303276 T3 DK1303276 T3 DK 1303276T3 DK 01940893 T DK01940893 T DK 01940893T DK 01940893 T DK01940893 T DK 01940893T DK 1303276 T3 DK1303276 T3 DK 1303276T3
Authority
DK
Denmark
Prior art keywords
loratadine
dosage form
bioavailable dosage
bioavailable
particle size
Prior art date
Application number
DK01940893T
Other languages
Danish (da)
English (en)
Inventor
Pananchukunath Manoj Kumar
Dinsheet Gupta
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1303276(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of DK1303276T3 publication Critical patent/DK1303276T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK01940893T 2000-07-17 2001-06-21 Biotilgængelig doseringsform af loratadin DK1303276T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN651DE2000 IN192160B (no) 2000-07-17 2000-07-17
PCT/IB2001/001098 WO2002005816A1 (en) 2000-07-17 2001-06-21 A bioavailable dosage form of loratadine

Publications (1)

Publication Number Publication Date
DK1303276T3 true DK1303276T3 (da) 2005-02-07

Family

ID=11097068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01940893T DK1303276T3 (da) 2000-07-17 2001-06-21 Biotilgængelig doseringsform af loratadin

Country Status (13)

Country Link
US (1) US20020035119A1 (no)
EP (1) EP1303276B1 (no)
AT (1) ATE278404T1 (no)
AU (1) AU2001274381A1 (no)
BR (1) BR0112597A (no)
DE (1) DE60106266T2 (no)
DK (1) DK1303276T3 (no)
ES (1) ES2230325T3 (no)
HK (1) HK1055256A1 (no)
IN (1) IN192160B (no)
PT (1) PT1303276E (no)
WO (1) WO2002005816A1 (no)
ZA (1) ZA200300439B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9241997B2 (en) 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
CA2628716C (en) * 2005-11-10 2016-09-27 Alphapharm Pty Ltd Process to control particle size
US20100104636A1 (en) * 2006-12-21 2010-04-29 Panagiotis Keramidas Pharmaceutical Compound and Composition
EP2318350A4 (en) * 2008-07-25 2012-11-28 Alphapharm Pty Ltd ATOVAQUONE WITH PARTICLE DIAMETER (D90) VARIANT FROM MORE THAN 3 muM TO ABOUT 10 muM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IL131317A (en) * 1999-08-09 2006-08-01 Cts Chemical Ind Ltd Binder for pharmaceutical compositions

Also Published As

Publication number Publication date
EP1303276A1 (en) 2003-04-23
WO2002005816A1 (en) 2002-01-24
DE60106266T2 (de) 2006-02-23
DE60106266D1 (de) 2004-11-11
PT1303276E (pt) 2005-02-28
ES2230325T3 (es) 2005-05-01
ATE278404T1 (de) 2004-10-15
HK1055256A1 (en) 2004-01-02
ZA200300439B (en) 2004-02-10
US20020035119A1 (en) 2002-03-21
BR0112597A (pt) 2003-08-12
EP1303276B1 (en) 2004-10-06
IN192160B (no) 2004-02-28
AU2001274381A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
NO20030713L (no) Oral faststoffdose vaksine
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
FI20000572A0 (fi) Implantaattien asettamiseen tarkoitettu laite
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
FR2806903B1 (fr) Prothese dentaire
EE200300287A (et) Modifitseeritud anorgaanilised osakesed
DE60112642D1 (de) Sandstrahlvorrichtung
DE10196204T1 (de) Orale Vorrichtungen
DE60220479D1 (de) Poloxymethylencopolymer und daraus hergestelltes formteil
DE60232573D1 (de) Damenbinde
NO20005979D0 (no) Dynamisk syklon
DK1303276T3 (da) Biotilgængelig doseringsform af loratadin
EP1164640A4 (en) SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME
GB0130923D0 (en) Semiconductor device manufacture and design
EE200200074A (et) Isotretinoiini biosaadav annustamisvorm
BR0201121B1 (pt) absorvente higiênico
HUP0401599A3 (en) Extended release oral dosage form
EP1357898A4 (en) ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE
NO20040866L (no) Ny oral forlenget frigivelses doseringsform
FR2810862B1 (fr) Ensemble de tables gigognes
GB2366667B (en) Manufacture of a semiconductor device
ES1050399Y (es) Servilletero
IL149461A0 (en) Semiconductor nanocrystalline materials and their uses
TW444928U (en) Particle cleaning device of pin-seat type stepper